Encision Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $194.1K
- Price
- $0.0115
- % Change (Daily % change from the live per-ticker quote feed.)
- -72.09%
- Volume
- 26.5K
About
Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.
Quick stats
Shares outstanding16.9M
Computed float6.3M
Float / shares37.1%
Key info
SectorHealthcare
IndustryMedical - Instruments & Supplies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000930775
Websitehttps://www.encision.com
AI Summary
AI-generated1/3
minorbearishoffering
Encision Completes $80,000 Private Placement
Encision Inc. completed an $80,000 private placement of common stock on September 8, 2026, issuing 2 million shares at $0.04 per share to a group of private investors consisting of the company's own directors.
The shares are restricted with no registration rights, and proceeds are earmarked for general working capital purposes. Following the closing, Encision has 18,879,645 total common shares outstanding, meaning the placement added roughly 12% to the pre-raise share count.
An insider-funded raise this small at four cents per share underscores how constrained the micro-cap surgical device maker's liquidity is, even though the directors' participation offers a modest signal of internal support.
Red flags
- raise of only $80,000 suggests acute working-capital constraints and limited access to outside capital
- entire investor group is the company's own directors
- shares priced at $0.04 on OTC Pink; roughly 12% dilution to existing holders
- restricted shares with no registration rights limit liquidity